Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Kurt

Approved

STANDARD

Kurt

S Kant Healthcare Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: f1ccdf1b24657cfc
Company: S Kant Healthcare Limited
Type: Standard

Approval Details

Approval Id: f1ccdf1b24657cfc
Drug Approval Philippines Name: Kurt
Product Name: Kurt
Registration Number: DRP-11543
Brand Name: Kurt
Generic Name: Hydrocortisone (As Acetate)
Dosage Form: Topical Cream
Dosage Strength: 10 mg/g (1% w/w)
Manufacturer: S Kant Healthcare Limited
Importer: AGlobal Care, Inc
Distributor: AGlobal Care, Inc
Issuance Date: 28 March 2022
Expiry Date: 05 August 2026
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

f1ccdf1b24657cfc

Type

Standard

Back to Philippines FDA Approvals

Kurt - Philippines FDA Drug Approval Details